34 related articles for article (PubMed ID: 21469209)
1. No association between polymorphisms in the glutamate transporter SLC1A2 and Parkinson's disease.
Appenzeller S; Schulte C; Thier S; Hopfner F; Pendziwiat M; Papengut F; Klein C; Hagenah J; Kasten M; Srulijes K; Berg D; Gasser T; Singleton A; Deuschl G; Kuhlenbäumer G
Mov Disord; 2013 Aug; 28(9):1305-6. PubMed ID: 23390085
[No Abstract] [Full Text] [Related]
2. PTPA variants and the risk for Parkinson's disease in diverse ancestry populations.
Ostrožovičová M; Mecheri Y; Al-Mubarak BR; Al-Tassan N; Makarious MB; Periñan MT; Bandres-Ciga S
Brain; 2023 Dec; 146(12):e120-e124. PubMed ID: 37467482
[No Abstract] [Full Text] [Related]
3. New gene involved in the pathogenesis of Parkinson's disease.
Toft M
Lancet Neurol; 2024 Jun; 23(6):550-552. PubMed ID: 38614109
[No Abstract] [Full Text] [Related]
4. The Crucial Roles of Pitx3 in Midbrain Dopaminergic Neuron Development and Parkinson's Disease-Associated Neurodegeneration.
Wang X; Chen X; Liu G; Cai H; Le W
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239960
[TBL] [Abstract][Full Text] [Related]
5. Developmental pathways linked to the vulnerability of adult midbrain dopaminergic neurons to neurodegeneration.
Prakash N
Front Mol Neurosci; 2022; 15():1071731. PubMed ID: 36618829
[TBL] [Abstract][Full Text] [Related]
6. Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?
Le W; Dong J; Li S; Korczyn AD
Neurosci Bull; 2017 Oct; 33(5):535-542. PubMed ID: 28866850
[TBL] [Abstract][Full Text] [Related]
7. Specificity of Pitx3-Dependent Gene Regulatory Networks in Subsets of Midbrain Dopamine Neurons.
Bifsha P; Balsalobre A; Drouin J
Mol Neurobiol; 2017 Sep; 54(7):4921-4935. PubMed ID: 27514757
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Transcription Factors in Animal Models of Parkinson Disease.
Blaudin de Thé FX; Rekaik H; Prochiantz A; Fuchs J; Joshi RL
Neural Plast; 2016; 2016():6097107. PubMed ID: 26881122
[TBL] [Abstract][Full Text] [Related]
9. PITX3 and risk for Parkinson's disease: a systematic review and meta-analysis.
Jiménez-Jiménez FJ; García-Martín E; Alonso-Navarro H; Agúndez JA
Eur Neurol; 2014; 71(1-2):49-56. PubMed ID: 24525476
[TBL] [Abstract][Full Text] [Related]
10. The VPS35 gene and Parkinson's disease.
Deng H; Gao K; Jankovic J
Mov Disord; 2013 May; 28(5):569-75. PubMed ID: 23536430
[TBL] [Abstract][Full Text] [Related]
11. Systematic genetic analysis of the PITX3 gene in patients with Parkinson disease.
Guo Y; Le WD; Jankovic J; Yang HR; Xu HB; Xie WJ; Song Z; Deng H
Mov Disord; 2011 Aug; 26(9):1729-32. PubMed ID: 21469209
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor PITX3 gene in Parkinson's disease.
Le W; Nguyen D; Lin XW; Rawal P; Huang M; Ding Y; Xie W; Deng H; Jankovic J
Neurobiol Aging; 2011 Apr; 32(4):750-3. PubMed ID: 19394114
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants of the PITX3 gene are not associated with late-onset sporadic Parkinson's disease in a Chinese population.
Cai Y; Ding H; Gu Z; Ma J; Chan P
Neurosci Lett; 2011 Jul; 498(2):124-6. PubMed ID: 21565251
[TBL] [Abstract][Full Text] [Related]
14. PITX3 polymorphism is associated with early onset Parkinson's disease.
Bergman O; Håkansson A; Westberg L; Nordenström K; Carmine Belin A; Sydow O; Olson L; Holmberg B; Eriksson E; Nissbrandt H
Neurobiol Aging; 2010 Jan; 31(1):114-7. PubMed ID: 18420308
[TBL] [Abstract][Full Text] [Related]
15. Association of transcription factor polymorphisms PITX3 and EN1 with Parkinson's disease.
Haubenberger D; Reinthaler E; Mueller JC; Pirker W; Katzenschlager R; Froehlich R; Bruecke T; Daniel G; Auff E; Zimprich A
Neurobiol Aging; 2011 Feb; 32(2):302-7. PubMed ID: 19345444
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]